Tivozanib
Tivozanib ATC Code L01EK03 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors - Tivozanib
Routes | Oral |
---|---|
FDA Approval Date | 2021-03-10 |
Molecular Formula | C22H19ClN4O5 |
Molecular Weight | 454.87 g/mol |
CAS Number | 475108-18-0 |
Brand names | Fotivda |